Laboratory Reagents Outlook: Ovine, Equine & Bovine Defibrinated Blood for Culture Media
公開 2026/04/02 17:21
最終更新
-
Global Leading Market Research Publisher QYResearch announces the release of its latest report "Defibrinated Animal Blood - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Defibrinated Animal Blood market, including market size, share, demand, industry development status, and forecasts for the next few years.
For microbiology laboratories, pharmaceutical quality control facilities, and biomedical research institutions, the preparation of culture media and diagnostic reagents requires high-quality, anticoagulant-free blood products that support the growth of fastidious microorganisms. The global Defibrinated Animal Blood market addresses this need through aseptically collected blood from healthy donor animals, mechanically defibrinated without anticoagulants or additives. A wide variety of defibrinated blood products exists depending on the animal source—ovine, equine, bovine, chicken, porcine, rabbit, and others—each with specific applications in research and diagnostics. As infectious disease testing and bacteriology workflows expand globally, demand for defibrinated animal blood continues to grow steadily.
The global market for Defibrinated Animal Blood was estimated to be worth US$ 351 million in 2025 and is projected to reach US$ 557 million, growing at a CAGR of 6.9% from 2026 to 2032. In 2024, global production reached 3,278,220 kiloliters, with an average selling price of US$ 0.28 per liter. This steady growth reflects consistent demand from clinical diagnostics and pharmaceutical quality control laboratories worldwide.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6097413/defibrinated-animal-blood
Species-Specific Blood Products for Diagnostic & Research Applications
Defibrinated blood products are drawn aseptically from healthy donor animals. The blood is mechanically defibrated and contains no anticoagulants or other additives. All blood is tested for color, platelet count (PCV), and hemolysis prior to pooling. A wide variety of defibrinated blood products exist, depending on the animal source (ovine, equine, bovine, chicken, porcine, etc.) and intended use. Products vary based on the defibrination method used, resulting in varying levels of purity and functionality.
The defibrination process removes fibrin through mechanical agitation while preserving red blood cells and serum components. Unlike anticoagulant-treated blood, defibrinated blood does not contain chemicals that may inhibit bacterial growth or interfere with certain assays, making it the preferred additive for culture media such as blood agar and chocolate agar.
Industry Segmentation: Animal Sources & Applications
The Defibrinated Animal Blood market is segmented by species origin and end-use application:
Sheep (Ovine): Defibrinated ovine blood holds a significant market share due to its widespread use in research settings and compatibility with various experimental models. Sheep blood is the standard additive for blood agar plates used in clinical microbiology for Streptococcus species identification.
Horse (Equine): Defibrinated horse blood is used less frequently than ovine blood and may be used in specific research areas. It is preferred for certain fastidious organisms and specialized culture media.
Bovine: Defibrinated bovine blood is widely used across various research fields, and its large-scale availability makes it cost-effective for many studies, including veterinary microbiology and pharmaceutical quality control.
Rabbit: Rabbit blood is used for specific applications where species-specific factors are required.
Others: Defibrinated chicken blood has a niche market with specific applications in research settings, primarily limited to avian research. Defibrinated porcine blood may have a smaller market share due to cost and availability. Other sources include mice and other animals for specialized research applications.
Application Segments
Biomedicine: Clinical diagnostic microbiology, hospital laboratories, and reference laboratories use defibrinated animal blood for blood agar preparation and pathogen culture from patient specimens. A large hospital network reported annual consumption of over 5,000 liters of defibrinated sheep blood across its microbiology departments.
Research: Pharmaceutical R&D, academic research, and veterinary diagnostic laboratories utilize defibrinated blood for bacterial culture, antibiotic susceptibility testing, vaccine development, and cell culture applications.
Technology Developments & Quality Standards
Over the past six months, several developments have shaped the market. Improved closed-system collection methods have enhanced sterility assurance and reduced contamination rates. Extended shelf-life formulations (up to 2 years with proper storage) have reduced waste for lower-volume laboratories. Enhanced quality control documentation (certificates of analysis for each lot) supports regulatory compliance for pharmaceutical and clinical customers.
The trend toward laboratory consolidation and centralized microbiology services has increased demand for consistent supply and larger packaging sizes. Regulatory requirements for culture media quality control (CLSI, ISO standards) drive demand for validated, documented blood products. Animal welfare and sourcing transparency have become considerations for some institutional purchasers.
Regional Market Dynamics
North America leads the defibrinated animal blood market, driven by high clinical microbiology testing volumes and strong pharmaceutical quality control requirements. The United States dominates with significant hospital and reference laboratory demand.
Europe follows closely, with strong microbiology infrastructure in Germany, France, and the UK, and regulatory requirements for culture media quality. Asia-Pacific is the fastest-growing region, with expanding clinical laboratory networks, increasing infectious disease testing, and growing pharmaceutical manufacturing in China, India, and Southeast Asia.
Competitive Landscape
Key players include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Trafalgar Scientific, HemoStat Laboratories, Dutscher, Serana Europe, Innovative Research Inc, Colorado Serum, SSI Diagnostica, SR Group, Szabo-Scandic, Rockland Immunochemicals, LABone Scientific, Biowest (BioNordic A/S), Pel-Freez Biologicals, EWC Diagnostics, Kraeber & Co. GmbH, Bio Nutrientes Do Brasil Ltda., Lampire Biological Laboratories, Quad Five (Materials Bio Inc.), Guangzhou Ruite Biotechnology, Obio Technology (Shanghai), Beijing Solarbio Science & Technology, Nanjing SenBeiJia Biological Technology, Changde BKMAM Biotechnology, and Beijing Baiao Leibo Technology.
Market Segmentation
The Defibrinated Animal Blood market is segmented as below:
By Company
Thermo Fisher Scientific
TCS Biosciences
BioMérieux
E & O Laboratories Ltd
Southern Biological
Trafalgar Scientific
HemoStat Laboratories
Dutscher
Serana Europe
Innovative Research Inc
Colorado Serum
SSI Diagnostica
SR Group
Szabo-Scandic
Rockland Immunochemicals, Inc.
LABone Scientific Co.Ltd.
Biowest (BioNordic A/S)
Pel-Freez Biologicals
EWC Diagnostics
Kraeber & Co. GmbH
Bio Nutrientes Do Brasil Ltda.
Lampire Biological Laboratories, Inc.
Quad Five (Materials Bio Inc.)
Guangzhou Ruite Biotechnology Co., Ltd.
Obio Technology (Shanghai) Corp., Ltd.
Beijing Solarbio Science & Technology Co.,Ltd.
Nanjing SenBeiJia Biological Technology Co., Ltd.
Changde BKMAM Biotechnology Co. Ltd.
Beijing Baiao Leibo Technology Co., Ltd.
Segment by Source
Bovine
Horse
Rabbit
Sheep
Others
Segment by Application
Biomedicine
Research
Exclusive Industry Outlook
Looking ahead, the convergence of defibrinated animal blood supply with automation in clinical microbiology and expanding diagnostic testing represents a steady growth opportunity. The trend toward laboratory consolidation will favor suppliers with robust quality systems and reliable supply chains. Development of synthetic or animal-free alternatives for certain applications may emerge but is unlikely to fully replace animal blood for specific fastidious organisms. Additionally, the expansion of infectious disease surveillance programs and antimicrobial resistance monitoring will create new demand across multiple species sources. The ability to offer defibrinated animal blood that combines consistent quality, sterility, and supply reliability—supported by comprehensive documentation and global distribution—will define competitive differentiation.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
For microbiology laboratories, pharmaceutical quality control facilities, and biomedical research institutions, the preparation of culture media and diagnostic reagents requires high-quality, anticoagulant-free blood products that support the growth of fastidious microorganisms. The global Defibrinated Animal Blood market addresses this need through aseptically collected blood from healthy donor animals, mechanically defibrinated without anticoagulants or additives. A wide variety of defibrinated blood products exists depending on the animal source—ovine, equine, bovine, chicken, porcine, rabbit, and others—each with specific applications in research and diagnostics. As infectious disease testing and bacteriology workflows expand globally, demand for defibrinated animal blood continues to grow steadily.
The global market for Defibrinated Animal Blood was estimated to be worth US$ 351 million in 2025 and is projected to reach US$ 557 million, growing at a CAGR of 6.9% from 2026 to 2032. In 2024, global production reached 3,278,220 kiloliters, with an average selling price of US$ 0.28 per liter. This steady growth reflects consistent demand from clinical diagnostics and pharmaceutical quality control laboratories worldwide.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6097413/defibrinated-animal-blood
Species-Specific Blood Products for Diagnostic & Research Applications
Defibrinated blood products are drawn aseptically from healthy donor animals. The blood is mechanically defibrated and contains no anticoagulants or other additives. All blood is tested for color, platelet count (PCV), and hemolysis prior to pooling. A wide variety of defibrinated blood products exist, depending on the animal source (ovine, equine, bovine, chicken, porcine, etc.) and intended use. Products vary based on the defibrination method used, resulting in varying levels of purity and functionality.
The defibrination process removes fibrin through mechanical agitation while preserving red blood cells and serum components. Unlike anticoagulant-treated blood, defibrinated blood does not contain chemicals that may inhibit bacterial growth or interfere with certain assays, making it the preferred additive for culture media such as blood agar and chocolate agar.
Industry Segmentation: Animal Sources & Applications
The Defibrinated Animal Blood market is segmented by species origin and end-use application:
Sheep (Ovine): Defibrinated ovine blood holds a significant market share due to its widespread use in research settings and compatibility with various experimental models. Sheep blood is the standard additive for blood agar plates used in clinical microbiology for Streptococcus species identification.
Horse (Equine): Defibrinated horse blood is used less frequently than ovine blood and may be used in specific research areas. It is preferred for certain fastidious organisms and specialized culture media.
Bovine: Defibrinated bovine blood is widely used across various research fields, and its large-scale availability makes it cost-effective for many studies, including veterinary microbiology and pharmaceutical quality control.
Rabbit: Rabbit blood is used for specific applications where species-specific factors are required.
Others: Defibrinated chicken blood has a niche market with specific applications in research settings, primarily limited to avian research. Defibrinated porcine blood may have a smaller market share due to cost and availability. Other sources include mice and other animals for specialized research applications.
Application Segments
Biomedicine: Clinical diagnostic microbiology, hospital laboratories, and reference laboratories use defibrinated animal blood for blood agar preparation and pathogen culture from patient specimens. A large hospital network reported annual consumption of over 5,000 liters of defibrinated sheep blood across its microbiology departments.
Research: Pharmaceutical R&D, academic research, and veterinary diagnostic laboratories utilize defibrinated blood for bacterial culture, antibiotic susceptibility testing, vaccine development, and cell culture applications.
Technology Developments & Quality Standards
Over the past six months, several developments have shaped the market. Improved closed-system collection methods have enhanced sterility assurance and reduced contamination rates. Extended shelf-life formulations (up to 2 years with proper storage) have reduced waste for lower-volume laboratories. Enhanced quality control documentation (certificates of analysis for each lot) supports regulatory compliance for pharmaceutical and clinical customers.
The trend toward laboratory consolidation and centralized microbiology services has increased demand for consistent supply and larger packaging sizes. Regulatory requirements for culture media quality control (CLSI, ISO standards) drive demand for validated, documented blood products. Animal welfare and sourcing transparency have become considerations for some institutional purchasers.
Regional Market Dynamics
North America leads the defibrinated animal blood market, driven by high clinical microbiology testing volumes and strong pharmaceutical quality control requirements. The United States dominates with significant hospital and reference laboratory demand.
Europe follows closely, with strong microbiology infrastructure in Germany, France, and the UK, and regulatory requirements for culture media quality. Asia-Pacific is the fastest-growing region, with expanding clinical laboratory networks, increasing infectious disease testing, and growing pharmaceutical manufacturing in China, India, and Southeast Asia.
Competitive Landscape
Key players include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Trafalgar Scientific, HemoStat Laboratories, Dutscher, Serana Europe, Innovative Research Inc, Colorado Serum, SSI Diagnostica, SR Group, Szabo-Scandic, Rockland Immunochemicals, LABone Scientific, Biowest (BioNordic A/S), Pel-Freez Biologicals, EWC Diagnostics, Kraeber & Co. GmbH, Bio Nutrientes Do Brasil Ltda., Lampire Biological Laboratories, Quad Five (Materials Bio Inc.), Guangzhou Ruite Biotechnology, Obio Technology (Shanghai), Beijing Solarbio Science & Technology, Nanjing SenBeiJia Biological Technology, Changde BKMAM Biotechnology, and Beijing Baiao Leibo Technology.
Market Segmentation
The Defibrinated Animal Blood market is segmented as below:
By Company
Thermo Fisher Scientific
TCS Biosciences
BioMérieux
E & O Laboratories Ltd
Southern Biological
Trafalgar Scientific
HemoStat Laboratories
Dutscher
Serana Europe
Innovative Research Inc
Colorado Serum
SSI Diagnostica
SR Group
Szabo-Scandic
Rockland Immunochemicals, Inc.
LABone Scientific Co.Ltd.
Biowest (BioNordic A/S)
Pel-Freez Biologicals
EWC Diagnostics
Kraeber & Co. GmbH
Bio Nutrientes Do Brasil Ltda.
Lampire Biological Laboratories, Inc.
Quad Five (Materials Bio Inc.)
Guangzhou Ruite Biotechnology Co., Ltd.
Obio Technology (Shanghai) Corp., Ltd.
Beijing Solarbio Science & Technology Co.,Ltd.
Nanjing SenBeiJia Biological Technology Co., Ltd.
Changde BKMAM Biotechnology Co. Ltd.
Beijing Baiao Leibo Technology Co., Ltd.
Segment by Source
Bovine
Horse
Rabbit
Sheep
Others
Segment by Application
Biomedicine
Research
Exclusive Industry Outlook
Looking ahead, the convergence of defibrinated animal blood supply with automation in clinical microbiology and expanding diagnostic testing represents a steady growth opportunity. The trend toward laboratory consolidation will favor suppliers with robust quality systems and reliable supply chains. Development of synthetic or animal-free alternatives for certain applications may emerge but is unlikely to fully replace animal blood for specific fastidious organisms. Additionally, the expansion of infectious disease surveillance programs and antimicrobial resistance monitoring will create new demand across multiple species sources. The ability to offer defibrinated animal blood that combines consistent quality, sterility, and supply reliability—supported by comprehensive documentation and global distribution—will define competitive differentiation.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
最近の記事
タグ